SNOA – sonoma pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
12/5
08:51 am
snoa
Medium
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices [Yahoo! Finance]
12/5
08:30 am
snoa
Medium
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
11/21
04:11 pm
snoa
Medium
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States [Yahoo! Finance]
11/21
04:06 pm
snoa
Medium
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
11/11
04:20 pm
snoa
High
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
1/3
05:02 pm
snoa
Low
Form 4 Sonoma Pharmaceuticals, For: Jan 02 Filed by: Thornton Bruce
1/3
05:02 pm
snoa
Low
Form 4 Sonoma Pharmaceuticals, For: Jan 02 Filed by: Trombly Amy Moss
1/3
05:02 pm
snoa
Low
Form 4 Sonoma Pharmaceuticals, For: Jan 02 Filed by: Weigerstorfer Philippe
1/3
05:02 pm
snoa
Low
Form 4 Sonoma Pharmaceuticals, For: Jan 02 Filed by: Birnbaum Jay E
1/3
05:02 pm
snoa
Low
Form 4 Sonoma Pharmaceuticals, For: Jan 02 Filed by: Dal Poggetto John
Show more
Top News Gainers
11/26 Sonoma Pharmaceuticals Announces Pricing of Approximately $1.6 million Public Offering of Common Stock 13.9%
11/14 Q2/2020 9/30/2019 EPS -0.910 ZacksConsensus N/A ActVsEst N/A - N/A 10.8%
1/23 Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology Division 9.8%
2/14 Q3/2020 12/31/2019 EPS -0.720 ZacksConsensus N/A ActVsEst N/A - N/A 9.8%
4/24 Form 4 Sonoma Pharmaceuticals, For: Apr 23 Filed by: Dal Poggetto John 7.3%
10/3 Form DEFA14A Sonoma Pharmaceuticals, 5.7%
12/31 Form 8-K Sonoma Pharmaceuticals, For: Dec 26 4.4%
7/29 Form DEF 14A Sonoma Pharmaceuticals, For: Sep 17 4.3%
5/22 Form 8-K Sonoma Pharmaceuticals, For: May 20 2.9%
5/31 Form 8-K Sonoma Pharmaceuticals, For: May 30 2.2%
Top News Decliners
10/1 Sonoma Pharmaceuticals Announces Management Changes -11.3%
8/13 Sonoma Pharmaceuticals Reports First Quarter FY 2020 Financial Results -7.1%
7/8 Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2019 Financial Results -5.1%
12/26 Form S-8 Sonoma Pharmaceuticals, -4.5%
7/12 Sonoma Pharmaceuticals Regains Compliance with Nasdaq® Minimum Bid Price Rule -4.2%
4/20 Form 8-K Sonoma Pharmaceuticals, For: Apr 14 -3.9%
11/27 Form 424B3 Sonoma Pharmaceuticals, -3.8%
6/12 Form 8-K Sonoma Pharmaceuticals, For: Jun 11 -1.4%
11/25 Sonoma Pharmaceuticals Announces Proposed Public Offering of Common Stock -1.1%
5/21 Sonoma Pharmaceuticals Sells Animal Health Rights in Asia and Europe for $2.7 million -0.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3